GPR124 Antibody

What is GPR124 and why is it significant for neurovascular research?

GPR124, also identified as KIAA1531 or TEM5 (Tumor Endothelial Marker 5), belongs to the G-protein coupled receptor 2 family and LN-TM7 subfamily . It functions as an orphan receptor (without a known ligand) and plays critical roles in CNS-specific angiogenesis and blood-brain barrier development . The significance of GPR124 stems from its essential role in neural vascularization, as global deletion or endothelial-specific deletion in mice results in embryonic lethality associated with abnormal angiogenesis of the forebrain and spinal cord . Moreover, GPR124 is significantly upregulated during angiogenesis and neoangiogenesis crucial for solid tumor growth, positioning it as both an important developmental regulator and a potential therapeutic target for cerebrovascular diseases . Its conserved expression across species and localization on endothelial cell surfaces makes it particularly valuable for investigating fundamental mechanisms of brain vascular development.

What are the typical applications for GPR124 antibodies in research?

GPR124 antibodies are primarily employed in immunohistochemistry (IHC) and enzyme-linked immunosorbent assay (ELISA) applications . For immunohistochemistry, these antibodies enable visualization of GPR124 expression patterns in tissues such as mouse small intestine and lung tissues, with recommended dilutions typically ranging from 1:50 to 1:500 . In neurovascular research, GPR124 antibodies facilitate the investigation of blood vessel invasion and migration into neuroepithelium and the establishment of blood-brain barrier properties . They can be combined with isolectin histochemical staining to assess co-localization patterns in endothelial cells, similar to VEGFR2 staining protocols . Additionally, GPR124 antibodies have been used in co-immunoprecipitation studies to verify protein interactions, such as those between GPR124 and DLG1, helping to elucidate molecular mechanisms underlying WNT7 signaling co-activation . These applications collectively enable researchers to study GPR124's role in developmental processes and pathological conditions.

How should researchers optimize GPR124 antibody dilution for immunohistochemistry?

Optimization of GPR124 antibody dilution for immunohistochemistry requires systematic titration to achieve specific staining with minimal background. The recommended starting dilution range for GPR124 antibody (such as 20050-1-AP) is 1:50-1:500 for IHC applications . When beginning optimization, researchers should:

• Perform a dilution series (e.g., 1:50, 1:100, 1:200, 1:350, 1:500) using appropriate positive control tissues such as mouse small intestine or lung tissue, where GPR124 expression has been confirmed .

• Pay careful attention to antigen retrieval methods, as this significantly impacts staining quality. For GPR124 detection, TE buffer at pH 9.0 is suggested, though citrate buffer at pH 6.0 may serve as an alternative .

• Include negative controls (omitting primary antibody) and known negative tissues to assess background and non-specific binding.

• Evaluate staining intensity, signal-to-noise ratio, and subcellular localization pattern at each dilution.

• Consider sample-specific variables, as the optimal dilution may vary depending on the tissue source, fixation method, and processing conditions .

Remember that optimal conditions must be determined for each specific testing system and experimental context rather than relying solely on published recommendations.

What are the storage and handling requirements for maintaining GPR124 antibody activity?

Proper storage and handling of GPR124 antibodies are essential for maintaining their activity and ensuring consistent experimental results. GPR124 antibodies such as 20050-1-AP should be stored at -20°C, where they remain stable for one year after shipment . The antibody is typically supplied in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3, which helps preserve activity during storage . For 20 μl sizes, the solution may contain 0.1% BSA as a stabilizer .

• Avoid repeated freeze-thaw cycles, which can lead to protein denaturation and reduced activity.

• Thaw antibodies completely before use and mix gently by inversion rather than vortexing to prevent protein denaturation.

• Keep antibodies on ice during experimental procedures to maintain stability.

• Return unused antibody to -20°C promptly after use.

• Note the expiration date and monitor for any signs of precipitation or contamination before use.

Following these handling practices ensures optimal antibody performance and reproducible experimental results.

How can researchers validate the specificity of GPR124 antibodies for developmental neurovascular studies?

Validating GPR124 antibody specificity for developmental neurovascular studies requires a multi-faceted approach to ensure genuine target detection, particularly given the temporal expression patterns of GPR124 during CNS development. A comprehensive validation strategy should include:

• Genetic Controls: Utilizing tissues from GPR124 knockout models as negative controls is the gold standard for specificity confirmation . The conditional knockout mice (Gpr124−/flox Tie2-cre) described in the literature provide ideal negative control tissues for validating antibody specificity .

• Expression Pattern Correlation: Compare antibody staining patterns with known GPR124 expression profiles. For instance, GPR124 mRNA expression peaks in embryonic brain at E13.5 (fourfold higher than in adult brain) . Antibody staining should reflect this temporal pattern.

• Co-localization Studies: Combine GPR124 immunostaining with endothelial markers (like isolectin) and pericyte markers (like PDGFRβ) to confirm the dual expression pattern in both cell types within the neurovascular unit .

• Cross-validation with Multiple Detection Methods: Compare results using different technical approaches:

  • Immunohistochemistry for spatial localization

  • Western blotting to confirm appropriate molecular weight (~185 kDa glycosylated, ~140 kDa deglycosylated)

  • Real-time qPCR for mRNA expression correlation

• Peptide Competition Assays: Pre-incubate the antibody with its immunizing peptide to demonstrate signal elimination in positive samples.

• Orthogonal Antibody Validation: Compare staining patterns using antibodies raised against different epitopes of GPR124 to confirm consistent localization patterns.

By implementing this rigorous validation approach, researchers can confidently interpret GPR124 staining patterns in developmental neurovascular studies with minimal risk of artifact or off-target effects.

What methodological approaches can resolve contradictory findings when studying GPR124 in different vascular beds?

Resolving contradictory findings in GPR124 expression or function across different vascular beds requires systematic methodological approaches that account for context-dependent heterogeneity. When faced with discrepant results:

• Standardize Detection Methods: Ensure consistent antibody concentrations, incubation times, and detection systems across all vascular beds being compared. For GPR124 antibodies, use the recommended dilution range (1:50-1:500) but standardize to a single optimized dilution for comparative studies .

• Employ Region-Specific Microdissection: Rather than analyzing whole organs, microdissect specific vascular regions for more precise analysis. Studies have shown that while GPR124 expression differs between embryonic and adult brain, no differences were observed between microdissected forebrain versus hindbrain regions .

• Temporal Resolution Analysis: Developmental timing significantly impacts GPR124 expression. Conduct time-course studies with precise developmental staging, as GPR124 mRNA expression peaks at E13.5 during brain development .

• Cell Type Isolation: Since GPR124 is expressed in both endothelial cells and pericytes , sorting these populations before analysis can resolve cell-type-specific differences that might otherwise appear contradictory in whole-tissue analyses.

• Consider Functional Context: Differences in GPR124 function may reflect context-dependent roles:

  • Analyze WNT7 pathway activity across vascular beds, as GPR124 serves as a WNT7-specific co-activator

  • Evaluate DLG1 interaction differences, as this binding partner influences GPR124 function

• Quantitative Comparative Analysis: Apply absolute quantification methods (e.g., digital PCR or calibrated protein standards) rather than relative comparisons to establish definitive expression levels across vascular beds.

By systematically addressing these methodological variables, researchers can determine whether apparent contradictions represent genuine biological differences or technical artifacts.

What experimental design is optimal for investigating GPR124's interaction with the Wnt7 signaling pathway?

Investigating GPR124's interaction with the Wnt7 signaling pathway requires a carefully structured experimental design that captures both physical interactions and functional consequences. An optimal approach should include:

• Co-Immunoprecipitation Studies with Domain Mapping:

  • Immunoprecipitate GPR124 from human cerebral microvascular endothelial cells (hCMECs) using a doxycycline-inducible FLAG-tagged GPR124 expression system

  • Create truncation and deletion mutants to map interaction domains, particularly focusing on the PDZ-binding motif (ETTV) at the C-terminus of GPR124, which has been shown to be essential for binding DLG1

  • Use non-induced hCMEC/GPR124i and parent hCMECs as negative controls to ensure specificity

• Mass Spectrometry Analysis of Interaction Partners:

  • Apply quantitative proteomics to identify all potential binding partners in the GPR124-Wnt7 pathway

  • Validate key interactions using reciprocal co-immunoprecipitation and proximity ligation assays

  • This approach successfully identified DLG1 as a major GPR124 interactor (43 peptides in the doxycycline-treated group versus zero in controls)

• Functional Reporter Assays:

  • Implement dose-response studies using Wnt-responsive luciferase reporters to quantify pathway activation

  • Compare wild-type GPR124 against mutants such as GPR124-Δ4aa (deletion of the PDZ-binding motif), which showed consistent reduction in activity

  • Include appropriate controls for pathway specificity (testing against non-Wnt7 ligands)

• Endothelial-Specific Conditional Knockout Models:

  • Utilize Tie2-cre-driven GPR124 deletion models to assess Wnt7 pathway activity in vivo

  • Compare phenotypes between global knockout and endothelial-specific knockout to distinguish cell-autonomous effects

  • Analyze region-specific differences in phenotype severity to correlate with Wnt7a/b expression patterns

• Structure-Function Analysis of Protein Domains:

  • Create domain-swapping chimeras between GPR124 and related GPCRs to identify Wnt7-specific interaction domains

  • Perform site-directed mutagenesis of key residues, particularly within the PDZ-binding motif

This comprehensive experimental design enables mechanistic dissection of how GPR124 functions as a WNT7-specific co-activator in canonical β-catenin signaling.

How can immunofluorescence techniques be optimized to visualize GPR124 subcellular localization in different neural cell types?

Optimizing immunofluorescence techniques for visualizing GPR124 subcellular localization in neural cell types requires specialized approaches tailored to GPR124's unique properties and expression patterns. A comprehensive optimization protocol should include:

• Fixation Method Selection:

  • Compare paraformaldehyde (4%) versus methanol fixation to determine which better preserves GPR124 epitopes while maintaining subcellular structures

  • For visualization of GPR124 in filopodia and cell borders, brief fixation (10-15 minutes) with 4% paraformaldehyde often provides optimal results

• Epitope Retrieval Optimization:

  • Test both recommended methods: TE buffer (pH 9.0) and citrate buffer (pH 6.0)

  • Implement a controlled comparison of retrieval durations (5-20 minutes) and temperatures (80-95°C)

  • For particularly sensitive neural tissues, enzyme-based retrieval (proteinase K) at low concentrations may be evaluated as an alternative

• Permeabilization Protocol Development:

  • Since GPR124 has both extracellular and intracellular domains, differential permeabilization can reveal topological information

  • For N-terminal epitopes, mild permeabilization or membrane-intact conditions are preferred

  • For C-terminal epitopes, complete permeabilization is required as demonstrated by studies showing that C-terminal myc-tagged GPR124 visualization required cell permeabilization

• Co-staining Strategy:

  • Combine GPR124 antibody (1:50-1:200 dilution) with markers for:

    • Actin cytoskeleton (phalloidin) to visualize co-localization with cell architecture

    • Neural cell type markers (GFAP for astrocytes, NeuN for neurons, Olig2 for oligodendrocytes)

    • Vascular markers (isolectin, CD31) for endothelial cells

    • PDGFRβ for pericytes

• Signal Amplification for Low Expression Contexts:

  • Implement tyramide signal amplification for tissues with lower GPR124 expression

  • Utilize high-sensitivity detection systems such as quantum dots or highly cross-adsorbed secondary antibodies

• Confocal Microscopy Parameters:

  • Use high numerical aperture objectives (1.3-1.4) for optimal resolution of membrane localization

  • Employ spectral unmixing for multi-color experiments to eliminate bleed-through

  • Implement deconvolution algorithms to enhance visualization of fine subcellular structures such as filopodia

This optimized approach will enable precise visualization of GPR124's characteristic localization to lateral cell borders and filopodia across different neural cell types .

What controls should be included when using GPR124 antibodies for blood-brain barrier research?

When using GPR124 antibodies for blood-brain barrier (BBB) research, a comprehensive set of controls is essential to ensure valid and interpretable results. Researchers should implement the following control strategy:

• Genetic Controls:

  • Positive Control: Wild-type mouse brain tissue, particularly from embryonic stages (E13.5) when GPR124 expression peaks

  • Negative Control: Tissue from GPR124 knockout models, specifically:

    • Global GPR124−/− knockout mice

    • Endothelial-specific knockout mice (Gpr124−/flox Tie2-cre)

  • Partial Control: Heterozygous mice (Gpr124+/−) to assess dose-dependent effects

• Tissue Controls:

  • Known Positive Tissues: Mouse small intestine and mouse lung tissues have been validated for GPR124 antibody reactivity

  • Developmental Controls: Compare embryonic versus adult brain samples to confirm expected expression differences (4-fold higher in embryonic brain)

  • Regional Controls: Include hindbrain samples alongside forebrain specimens, as these show similar GPR124 expression despite different phenotypic outcomes in knockout models

• Cellular Controls:

  • Cell Type Verification: Co-stain with isolectin (endothelial marker) and PDGFRβ (pericyte marker) to verify cell type-specific expression

  • Primary Cell Controls: Include isolated human primary brain-derived pericytes and endothelial cells as reference standards

• Technical Controls:

  • Antibody Specificity Control: Pre-adsorption with immunizing peptide

  • Secondary Antibody Control: Omit primary antibody to assess non-specific binding

  • Isotype Control: Use matched isotype (Rabbit IgG) at equivalent concentration

  • Dilution Controls: Include both lower (1:25) and higher (1:1000) dilutions than recommended (1:50-1:500) to verify staining specificity

• Functional Controls:

  • Bioelectric Impedance: Compare BBB integrity between wild-type and GPR124-modulated models

  • Permeability Assays: Include standard permeability markers (e.g., fluorescent dextrans of various molecular weights)

This comprehensive control strategy ensures that findings related to GPR124's role in BBB development and function can be interpreted with confidence and reproducibility.

How can researchers troubleshoot non-specific binding when using GPR124 antibodies in complex tissue samples?

Troubleshooting non-specific binding when using GPR124 antibodies in complex tissue samples requires a systematic approach to identify and eliminate potential sources of background. Researchers can implement the following sequential troubleshooting protocol:

• Antibody Dilution Optimization:

  • Start with the higher end of the recommended dilution range (1:500) for GPR124 antibodies

  • Perform a dilution series (1:100, 1:200, 1:350, 1:500, 1:750, 1:1000) to identify the optimal signal-to-noise ratio

  • Compare staining patterns across dilutions, focusing on known GPR124-positive structures while monitoring background

• Blocking Protocol Enhancement:

  • Implement a dual blocking strategy using both protein blockers and species-specific immunoglobulins

  • Test extended blocking times (2-4 hours) at room temperature versus standard protocols

  • Consider specialized blocking agents:

    • 5% BSA with 0.3% Triton X-100 for balanced protein blocking and permeabilization

    • Add 2-5% serum from the species in which the secondary antibody was raised

    • Include 0.1-0.3% glycine to block free aldehyde groups from fixation

• Washing Optimization:

  • Increase wash duration and frequency (5-6 washes of 10 minutes each)

  • Test different wash buffers, comparing PBS-T (0.1% Tween-20), TBS-T, and high-salt variants

  • Implement graded wash series (starting with higher salt concentration and decreasing)

• Antigen Retrieval Modification:

  • Compare the recommended TE buffer (pH 9.0) against citrate buffer (pH 6.0)

  • Test different retrieval durations and temperatures

  • For particularly problematic samples, evaluate enzymatic retrieval methods

• Secondary Antibody Selection:

  • Switch to highly cross-adsorbed secondary antibodies specifically designed to minimize cross-reactivity

  • Reduce secondary antibody concentration while extending incubation time

  • Consider using Fab fragments instead of whole IgG molecules

• Sample-Specific Adjustments:

  • For highly autofluorescent tissues, pretreat with Sudan Black B (0.1-0.3%)

  • Implement quenching steps (e.g., 0.1% sodium borohydride) to reduce background

  • For tissues with high endogenous peroxidase activity, include additional quenching steps with 3% H₂O₂

• Detection System Modification:

  • Switch between enzymatic and fluorescent detection systems to determine if background is detection-specific

  • For IHC applications, implement low DAB concentration with extended development time

By systematically applying this troubleshooting protocol, researchers can significantly reduce non-specific binding and achieve clean, interpretable GPR124 staining even in complex neural tissues.

What quantitative analysis methods are most appropriate for GPR124 expression studies across different developmental stages?

Quantitative analysis of GPR124 expression across developmental stages requires methods that account for spatiotemporal dynamics while ensuring reproducibility and statistical validity. The following approaches are recommended based on the biological characteristics of GPR124:

• Real-Time Quantitative PCR (RT-qPCR):

  • Implement absolute quantification using standard curves to enable direct comparison across developmental timepoints

  • Design primers spanning exon junctions to avoid genomic DNA amplification

  • Include multiple reference genes validated for stability across developmental stages

  • This approach successfully demonstrated a fourfold increase in GPR124 mRNA expression in embryonic brain compared to adult brain, with peak levels at E13.5

• Western Blot Densitometry with Standardization:

  • Use recombinant GPR124 protein standards at known concentrations to generate calibration curves

  • Account for GPR124's glycosylation status (~185 kDa glycosylated versus ~140 kDa deglycosylated form)

  • Implement fluorescent secondary antibodies for wider linear dynamic range compared to chemiluminescence

  • Normalize to both loading controls and total protein staining to account for developmental changes in housekeeping genes

• Quantitative Immunohistochemistry:

  • Apply tissue microarray approaches for high-throughput analysis across developmental stages

  • Implement whole-slide scanning with automated image analysis software

  • Use calibration slides with known quantities of target protein for standardization

  • Employ cell-type specific quantification through multi-channel analysis (isolectin, PDGFRβ co-staining)

• Single-Cell Analysis:

  • Implement flow cytometry on dissociated tissues with carefully optimized GPR124 antibody concentration

  • Utilize single-cell RNA-seq to capture cell-type specific expression dynamics

  • Correlate GPR124 expression with endothelial and pericyte markers across developmental trajectories

• Computational Analysis Methods:

  • Apply linear mixed effects models to account for within-subject correlation across timepoints

  • Implement segmented regression to identify transition points in expression patterns

  • Utilize bootstrap resampling for robust confidence interval estimation

  • When comparing microdissected regions, apply appropriate corrections for multiple comparisons (e.g., FDR)

• Spatial Transcriptomics Integration:

  • Combine in situ hybridization data with immunohistochemistry to correlate mRNA and protein expression patterns

  • Implement digital spatial profiling for region-specific quantification

  • Perform co-localization analysis with vascular markers using Manders' overlap coefficient and Pearson's correlation coefficient

This multi-modal quantitative approach provides comprehensive measurement of GPR124 expression dynamics across developmental stages while accounting for its unique biological characteristics.

How can researchers design experiments to distinguish between GPR124's roles in endothelial cells versus pericytes?

Designing experiments to distinguish between GPR124's roles in endothelial cells versus pericytes requires sophisticated approaches that can isolate cell-type specific functions while accounting for intercellular crosstalk. A comprehensive experimental design should include:

• Cell-Type Specific Genetic Manipulation:

  • Endothelial-Specific Targeting: Utilize Tie2-Cre or Cdh5-CreERT2 systems for endothelial-specific deletion of GPR124

  • Pericyte-Specific Targeting: Employ PDGFRβ-Cre or NG2-CreERT2 for pericyte-specific manipulation

  • Temporal Control: Implement tamoxifen-inducible systems to distinguish between developmental and maintenance roles

  • Combinatorial Approach: Create dual conditional knockouts to assess synergistic effects

• Co-Culture Systems with Selective Manipulation:

  • Establish endothelial-pericyte co-culture systems with selective GPR124 knockdown/overexpression in either cell type

  • Measure:

    • Barrier function using TEER (transendothelial electrical resistance)

    • Migration using scratch assays and live-cell imaging

    • WNT7 pathway activation using reporter constructs

  • Exogenous overexpression of GPR124 in brain endothelial cells (bEnd3 and hCMECs) has been shown to enhance both migration and barrier properties

• Cell-Type Specific RNA-Seq and Proteomics:

  • Implement FACS-based isolation of endothelial cells and pericytes from developing brain

  • Perform comparative transcriptomics and proteomics to identify cell-type specific GPR124-dependent pathways

  • Apply pathway enrichment analysis to distinguish primary versus secondary effects

• High-Resolution Imaging of Cell-Type Specific Phenotypes:

  • Use immunofluorescence co-staining with isolectin (endothelial) and PDGFRβ (pericyte) markers

  • Apply super-resolution microscopy to visualize subcellular localization differences

  • Implement intravital imaging in reporter mouse models to track dynamic interactions

• Conditioned Media Experiments:

  • Culture GPR124-deficient or GPR124-overexpressing endothelial cells and collect conditioned media

  • Apply to wild-type pericytes and vice versa

  • Measure phenotypic responses to identify paracrine signaling components

• Chimeric Analysis:

  • Create mosaic situations where GPR124 is deleted in one cell type but not the other

  • Use transplantation approaches or inducible systems with sparse recombination

  • Analyze cell-autonomous versus non-cell-autonomous effects

• Quantitative Analysis Framework:

  • Develop mathematical models that incorporate:

    • Cell-type specific expression levels of GPR124

    • Spatial relationships between endothelial cells and pericytes

    • Temporal dynamics of gene expression changes

By implementing this comprehensive experimental design, researchers can systematically dissect the distinct and potentially interacting roles of GPR124 in endothelial cells versus pericytes during neurovascular development and in pathological conditions.